Progenics Pharmaceuticals Inc (NASDAQ:PGNX)

6.38
Delayed Data
As of Apr 17
 -0.14 / -2.15%
Today’s Change
3.10
Today|||52-Week Range
7.84
-15.61%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2014
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Revenue and IncomeNet Revenues1.8M1.5M41.7M-571.0K
 
 
 
 
 
Cost of Goods Sold172.0K327.0K329.0K27.0K
 
 
 
 
 
Depreciation And Amortization144.0K133.0K142.0K126.0K
 
 
 
 
 
 
Operating ExpensesGross Income1.5M1.0M41.2M-724.0K
 
 
 
 
 
General Expenses10.3M11.7M10.6M10.0M
 
 
 
 
 
Research And Development6.9M7.8M6.7M6.2M
 
 
 
 
 
Total Operating Expenses10.6M12.2M11.1M10.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-8.8M-10.7M30.6M-10.8M
 
 
 
 
 
Extraordinary Credit----7.3M--
 
 
Extraordinary Charge-500.0K-400.0K-1.1M-2.2M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-9.3M-11.1M36.7M-12.9M
 
 
 
 
 
Income Taxes0.00-1.0K-227.0K-761.0K
 
 
 
 
Net Income-9.3M-11.1M37.0M-12.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS64.0M63.7M69.6M69.6M
 
 
 
 
 
Shares To Calculate EPS Diluted64.0M63.7M72.9M69.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.15-$0.17$0.51-$0.18
 
 
 
 
 
EPS Diluted-$0.15-$0.17$0.51-$0.18
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account